Sequoia Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.07M Buy
26,461
+2,966
+13% +$232K 0.01% 459
2025
Q1
$1.7M Buy
23,495
+15,417
+191% +$1.12M 0.01% 472
2024
Q4
$598K Buy
8,078
+1,176
+17% +$87.1K 0.01% 741
2024
Q3
$455K Sell
6,902
-1,949
-22% -$129K ﹤0.01% 786
2024
Q2
$818K Sell
8,851
-2,695
-23% -$249K 0.01% 536
2024
Q1
$1.1M Sell
11,546
-2,212
-16% -$211K 0.01% 448
2023
Q4
$1.05M Buy
13,758
+4,095
+42% +$312K 0.01% 513
2023
Q3
$669K Sell
9,663
-3,700
-28% -$256K 0.01% 430
2023
Q2
$1.26M Sell
13,363
-1,400
-9% -$132K 0.02% 309
2023
Q1
$1.22M Buy
14,763
+1,340
+10% +$111K 0.03% 280
2022
Q4
$1M Buy
13,423
+5,247
+64% +$391K 0.02% 291
2022
Q3
$676K Sell
8,176
-481
-6% -$39.8K 0.02% 248
2022
Q2
$823K Sell
8,657
-524
-6% -$49.8K 0.02% 251
2022
Q1
$1.08M Buy
9,181
+941
+11% +$111K 0.03% 249
2021
Q4
$1.07M Buy
+8,240
New +$1.07M 0.03% 234
2021
Q3
Sell
-7,694
Closed -$797K 320
2021
Q2
$797K Buy
7,694
+957
+14% +$99.1K 0.03% 223
2021
Q1
$563K Buy
6,737
+357
+6% +$29.8K 0.02% 246
2020
Q4
$582K Buy
6,380
+6
+0.1% +$547 0.03% 229
2020
Q3
$509K Sell
6,374
-96
-1% -$7.67K 0.03% 223
2020
Q2
$447K Sell
6,470
-115
-2% -$7.95K 0.03% 231
2020
Q1
$414K Sell
6,585
-48
-0.7% -$3.02K 0.03% 218
2019
Q4
$516K Buy
6,633
+429
+7% +$33.4K 0.03% 214
2019
Q3
$455K Buy
6,204
+294
+5% +$21.6K 0.03% 206
2019
Q2
$364K Buy
5,910
+1,734
+42% +$107K 0.03% 250
2019
Q1
$266K Buy
+4,176
New +$266K 0.02% 293